Does a polypill-based strategy reduce systolic blood pressure and LDL cholesterol levels in a socioeconomically vulnerable minority population compared to usual care?
A polypill-based strategy effectively lowers systolic blood pressure and LDL cholesterol in socioeconomically vulnerable minority populations compared to usual care.
A polypill-based strategy led to greater reductions in systolic blood pressure and LDL cholesterol level than were observed with usual care in a socioeconomically vulnerable minority population. (Funded by the American Heart Association Strategically Focused Prevention Research Network and the National Institutes of Health; ClinicalTrials.gov number, NCT02278471.).
Muñoz et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: